U.S. Markets open in 3 hrs 43 mins
  • S&P Futures

    3,654.00
    -6.50 (-0.18%)
     
  • Dow Futures

    29,714.00
    -90.00 (-0.30%)
     
  • Nasdaq Futures

    12,434.25
    -18.00 (-0.14%)
     
  • Russell 2000 Futures

    1,831.70
    -3.80 (-0.21%)
     
  • Crude Oil

    44.44
    -0.11 (-0.25%)
     
  • Gold

    1,833.50
    +14.60 (+0.80%)
     
  • Silver

    24.38
    +0.29 (+1.20%)
     
  • EUR/USD

    1.2058
    -0.0020 (-0.1688%)
     
  • 10-Yr Bond

    0.9340
    0.0000 (0.00%)
     
  • Vix

    20.93
    +0.36 (+1.75%)
     
  • GBP/USD

    1.3348
    -0.0075 (-0.5580%)
     
  • USD/JPY

    104.6920
    +0.3760 (+0.3604%)
     
  • BTC-USD

    19,112.86
    -58.88 (-0.31%)
     
  • CMC Crypto 200

    374.97
    -4.89 (-1.29%)
     
  • FTSE 100

    6,388.97
    +4.24 (+0.07%)
     
  • Nikkei 225

    26,800.98
    +13.44 (+0.05%)
     

Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update

STOUGHTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, May 8, 2019 at 4:30 p.m. Eastern Time. The Company will discuss its financial results and provide a corporate update.

Conference Call Information:

To access the conference call, please dial (888) 698-6931 (U.S.) or (805) 905-2993 (International) and refer to Conference ID: 419-0474. An audio webcast will be accessible from the Investor Relations section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com